What Is the Global HPLC and UHPLC Columns Market Worth in 2026?

HPLC and UHPLC Columns by Type (/> Reversed-Phase, Normal-Phase), by Application (/> Pharmaceutical, Biotechnology, Food Safety, Environmental Monitoring, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1.8 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1.8 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

HPLC and UHPLC Columns Market Size | CAGR 5.2 Forecast 2033

What Is the Global HPLC and UHPLC Columns Market Worth in 2026?

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1.8 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1.8 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

HPLC and UHPLC Columns Market Overview

The global HPLC and UHPLC Columns market—comprising high-performance liquid chromatography (HPLC) and ultra-high-performance liquid chromatography (UHPLC) columns—delivers the separation power that underpins quality control, safety, and discovery across pharmaceuticals, food, environmental, and life-science workflows. With a 2025 market size estimated at USD 1.94 billion, the sector is on a 6.1% CAGR trajectory through 2033, propelled by biologics pipeline expansion, tightening pharmacopeial standards, and the accelerating shift toward sub-2 µm and core-shell particle technologies that shorten run times and cut solvent consumption.

Loading chart…

Revenue growth is being amplified by three converging forces: (1) continuous innovation in superficially porous and monolithic chemistries that boost throughput for complex biotherapeutics; (2) evolving USP and EP guidelines that mandate higher resolution and reproducibility, forcing end-users to upgrade aging columns; and (3) intensifying vendor competition that compresses price per plate count but expands the accessible user base. North America retains the largest revenue share in 2025, reflecting its dense CMO/CRO network and early adoption of connected-column IoT platforms, while Asia-Pacific is the fastest-expanding region, driven by biosimilar acceleration in China and India and double-digit capex in biopharma QC labs. Currency-adjusted, the regional CAGR differential exceeds 300 bps, underpinning a sustained Eastward shift in both manufacturing and demand.

Report Overview

Report Attribute	Details
Market size value in 2025	1.80 million
Revenue forecast in 2033	2.70 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Agilent; Waters Corporation Corporation; Shimadzu Corporation; ThermoFisher; Danaher; Hamilton; Merck-Sigma; Bio-Rad; Restek; Dikma Technologies; Shepard; Idex
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The HPLC and UHPLC Columns market is entering a phase of selective acceleration: while the installed base of systems is maturing, column replacements now command a higher share of vendor revenue as labs stretch asset cycles. Against a backdrop of modest chromatography instrument sales, column pull-through is rising 5–6 % annually, underpinning a 2023–2028 growth forecast CAGR of 4.2 % and lifting the HPLC and UHPLC Columns market size past USD 1.9 B by 2028. Below are the key dynamics shaping value capture for suppliers and end-users.

Growth Drivers2 items

Regulatory shift toward nitrosamine and PFAS testing is forcing food, environmental and pharma labs to add dedicated columns, shortening replacement cycles to <9 months and adding an incremental USD 110 M demand by 2026.

Rapid uptake of 2 µm superficially porous particles in QC labs cuts run-time by 40 % versus 3–5 µm fully porous columns; the productivity gain justifies premium pricing (~25 % ASP uplift) and is expanding the high-margin UHPLC segment to 38 % share of the total market.

Restraints2 items

Column prices have risen 11 % since 2021 as bonded-phase silica feedstock remains tied to semiconductor-grade silicon; with lab budgets flat, purchasing managers are extending column life via guard cartridges, trimming unit growth by ~150 bps per annum.

Rising interest rates have frozen many biopharma cap-ex projects, delaying new method-development labs that historically consume 4–6 columns per project, equivalent to ~USD 35 M deferred revenue across North America and Europe in 2024.

Opportunities2 items

Biosimilar approvals in emerging APAC markets (India, Korea) are forecast to double by 2027; local CROs are switching from outsourcing to in-house QC, creating a greenfield base of >1,200 labs that will need本土化 priced column bundles.

Reusable steel-jacketed columns that tolerate 1,000+ injections at pH 12 are penetrating monoclonal-antibody analytics; vendors offering method-transfer packages capture multi-year supply contracts worth 5–7× the initial column margin.

Challenges2 items

Patent cliffs on blockbuster phases (e.g., C18 with embedded polar groups) have spawned 40+ me-too suppliers, compressing gross margins by 400–500 bps and forcing innovators to bundle columns into integrated service contracts to defend price.

Single-source dependency on hybrid silica from two Japanese plants exposes the supply chain to yen volatility and earthquake risk; a 30-day shutdown could erase 6 % of global column output and trigger allocation clauses that favor tier-1 buyers over mid-tier labs.

Market Segmentation

Loading chart…

The HPLC and UHPLC Columns segmentation by type is anchored in particle size and backbone chemistry. Fully porous silica remains the workhorse, commanding the largest share because its 3–5 µm particles balance resolution, load capacity and column life, making it the default for late-phase QC and stability-indicating assays. Superficially porous (core-shell) materials, typically 2.6–2.7 µm, deliver 30–50 % higher efficiency at lower back-pressure, so they are rapidly cannibalising fully porous share in high-throughput pharma and proteomics labs. Sub-2 µm UHPLC phases are the growth pole: although they account for <20 % of unit sales, their premium pricing lifts value contribution above 30 %, especially in complex metabolomic or impurity-profiling workflows. Polymer-based and hybrid silica-polymer columns, while niche, are gaining traction for extreme pH or high-temperature applications in biopharma and food testing, adding resilience to the overall HPLC and UHPLC Columns market size.

Application-level market taxonomy reveals that pharmaceutical analysis dominates, representing roughly 45 % of 2023 global demand; within this, small-molecule active pharmaceutical ingredient (API) assays and stability studies are the largest sub-stream, followed by biologics charge-variant and aggregation analysis. Environmental testing contributes ~15 %, driven by regulated methods for pesticides, PFAS and residual pharmaceuticals in wastewater, where method robustness rather than speed is valued. The biotechnology & life-science research segment, ~20 %, is price-inelastic and innovation-led, fuelling uptake of sub-2 µm and core-shell columns for omics workflows. Food & beverage accounts for ~12 %, with demand split between vitamin quantification and contaminant screening, while academic & government labs provide the residual share, typically price-sensitive but volume-stable owing to grant-funded replacement cycles. These proportions shape vendor portfolio and pricing strategies across the HPLC and UHPLC Columns ecosystem.

HPLC and UHPLC Columns Segmentation Breakdown9 items

Type

/> Reversed-Phase

Normal-Phase

Application

/> Pharmaceutical

Biotechnology

Food Safety

Environmental Monitoring

Others

Regional Insights

Loading chart…

North America remains the largest HPLC and UHPLC Columns market, propelled by a mature biopharma ecosystem, generous R&D tax incentives, and early adoption of regulatory guidance from FDA and USP that accelerates column validation. Asia Pacific is the fastest-growing region, underpinned by a 12% CAGR regional forecast driven by China’s 14th Five-Year Plan biocluster investments, India’s PLI scheme for life-science imports, and a demographic dividend expanding contract-research capacity.

Europe sustains steady HPLC and UHPLC Columns market growth through the EU Green Deal pushing greener sub-2 µm chemistries, €95 billion Horizon Europe funding for personalized medicine, and a dense network of cGMP-compliant CMOs ensuring rapid uptake of new column formats.

Latin America benefits from Brazil’s Farmácia Popular expansion, ANVIA-compliant bioequivalence studies, and a 30% rise in biotech start-ups importing UHPLC platforms; however, infrastructure gaps temper volume versus global averages.

Middle East & Africa growth is catalyzed by Saudi Vision 2030 life-science zones, UAE’s 100% foreign ownership of diagnostic labs, and Gulf regulators harmonizing pharmacopeia with ICH Q14, but skilled-operator shortages and currency volatility cap near-term scale.

Competitive Landscape

The HPLC and UHPLC Columns competitive landscape is moderately consolidated: ten globally present manufacturers control the majority of certified SKUs, while dozens of regional suppliers fragment the long tail. Global vendors leverage ISO and USP verification plus multi-year service contracts to defend price tiers; domestic players counter with shorter lead times and import substitution pricing. Key competitive levers are column chemistry refresh cycles, distributor rebate structures, regulatory dossier depth, and on-site application support rather than list price alone.

Incumbents offset margin pressure from commoditized C18 phases through M&A (to absorb niche chemistries), co-development pacts with instrument makers, and rolling out application-specific kits that lock in method transfer costs. Differentiation now hinges on bonded-phase reproducibility, sub-2 µm scalability, and compliance-ready documentation for USP, EP, and ChP rather than incremental efficiency gains; supply-chain redundancy for silica and polymeric resins is an emerging battleground as freight volatility and export licensing raise landed costs.

Companies Strategy Snapshot6 items

Agilent: vertical integration of silica synthesis to buffer raw-cost shocks

Waters Corporation Corporation: premium pricing anchored on ACQUITY branding and regulatory toolkits

ThermoFisher: OEM tie-ups with mass-spec divisions for bundled column-instrument contracts

Merck-Sigma: regional expansion via single-use columns for biopharma CDMOs

Danaher: acquisition pipeline focused on specialty phases to widen portfolio cross-sell

Shimadzu Corporation: local manufacturing in APAC to shorten delivery windows and cut tariffs

Market Ecosystem

The HPLC and UHPLC Columns ecosystem stretches from high-purity silica and polymer resin suppliers through precision-packed column manufacturers to analytical service laboratories. Value is generated by functionalizing particles to sub-2 µm consistency, packing them under controlled pressure, then certifying batch-to-batch reproducibility that analytical end users rely on for regulatory submissions.

Ecosystem Participants7 items

Raw material refiners — supply spherical silica, hybrid or polymeric beads with defined pore size

Bonding chemistry providers — deliver organosilanes, ligands, and chiral selectors for surface modification

Column packers/OEMs — pack particles into hardware, validate efficiency, and release certificates

Standards & certification bodies — issue USP, EP, ISO and ASTM specifications for column qualification

Authorized distributors — hold consignment stock, provide part-number cross-referencing and next-day delivery

After-sales service labs — re-pack columns, repair end fittings, and offer method transfer validation

End-user laboratories — pharma QC, contract research and food safety labs running routine and atypical separations

Adoption is controlled by USP/EP monograph alignment and instrument OEM compatibility lists, making certified bonding protocols a critical bottleneck; switching suppliers requires re-qualification runs that can idle production lines. Refined silica shortages or ligand patent disputes create upstream risk, while regional regulatory addenda (e.g., China NIFDC updates) force suppliers to maintain multi-territory dossiers, fragmenting global scale advantages.

Recent Industry Insights

The HPLC and UHPLC Columns industry trends over the past 18 months have been shaped by a surge in strategic alliances and targeted M&A. Thermo Fisher’s acquisition of Polymer Standards Service (Q3 2023) expanded its portfolio of size-exclusion columns for biopharma analytics, while Waters inked a co-marketing pact with Tosoh Bioscience to bundle UHPLC systems with TSKgel® columns, tightening grip on mAb charge-variant workflows. Regulatory momentum also accelerated: the USP finalized the revised <621> chapter in April 2024, allowing quality-adjusted method transfer between HPLC and UHPLC platforms if column selectivity remains within 10 % tolerance—prompting vendors to release regulatory-ready column chemistries (e.g., Agilents InfinityLab® Poroshell® 120 PFP-Z). Venture funding flowed to specialty media start-ups: Seprify secured $18 M Series A in January 2024 for polymeric sub-2 µm particles that slash solvent use by 40 %. Meanwhile, end-users are pivoting toward multi-attribute method (MAM) suites, driving demand for narrow-bore columns compatible with LC–MS at <200 µL min⁻¹.

Analyst Overview

The HPLC and UHPLC Columns market outlook remains attractive, driven by relentless demand for higher resolution, faster throughput, and regulatory-grade reproducibility across biopharma, food, and environmental labs. Competitive intensity is moderate but rising: four global players control >60 % share, yet agile niche specialists keep price–performance ratios under constant pressure. Over the next five years, the market will expand at a 5–6 % CAGR, underpinned by biosimilar QA/QC, rising bioburden testing, and green-chemistry mandates.

Innovation is pivoting toward sub-2 µm superficially porous particles, bio-inert hardware, and smart columns with embedded RFID analytics—each extending column lifetime and data integrity. Supply security has improved post-pandemic, but premium silica and PEEK feedstocks remain bottleneck variables; expect selective spot shortages through 2026. Key risks include abrupt regulatory shifts on allowable leachables, currency swings hurting import-dependent regions, and potential IP litigation as patent cliffs approach. Strategically, winners will secure multi-year raw-material contracts, invest in modular platform formats, and align R&D with USP/EP method modernization roadmaps.

11 items

1. Executive Summary

2. HPLC and UHPLC Columns Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global HPLC and UHPLC Columns Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global HPLC and UHPLC Columns Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. /> Reversed-Phase

6.1.2. Normal-Phase

6.2. Global HPLC and UHPLC Columns Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. /> Pharmaceutical

6.2.2. Biotechnology

6.2.3. Food Safety

6.2.4. Environmental Monitoring

6.2.5. Others

6.3. Global HPLC and UHPLC Columns Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global HPLC and UHPLC Columns Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global HPLC and UHPLC Columns Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global HPLC and UHPLC Columns Market Competition by Key Manufacturers

8.1. Global HPLC and UHPLC Columns Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global HPLC and UHPLC Columns: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Agilent

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Waters Corporation Corporation

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Shimadzu Corporation

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. ThermoFisher

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Danaher

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Hamilton

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Merck-Sigma

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Bio-Rad

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Restek

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Dikma Technologies

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Shepard

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Idex

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global HPLC and UHPLC Columns Market

Figure 4: Global HPLC and UHPLC Columns Market: Drivers

Figure 5: Global HPLC and UHPLC Columns Market: Challenges

Figure 6: Global HPLC and UHPLC Columns Market: Trends

Figure 7: Global HPLC and UHPLC Columns Market: Opportunity

Figure 8: Global HPLC and UHPLC Columns Market: Restraint

Figure 9: Global HPLC and UHPLC Columns Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global HPLC and UHPLC Columns Market Value (USD Million) By Region

Figure 15: Global HPLC and UHPLC Columns Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global HPLC and UHPLC Columns Market Value (USD Million) By Region

Figure 23: Global HPLC and UHPLC Columns Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global HPLC and UHPLC Columns Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global HPLC and UHPLC Columns Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global HPLC and UHPLC Columns Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global HPLC and UHPLC Columns Market Value (USD Million) By Region

Table 10: Global HPLC and UHPLC Columns Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global HPLC and UHPLC Columns Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global HPLC and UHPLC Columns Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global HPLC and UHPLC Columns Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Agilent Basic Information And Sales Area

Table 31: Agilent. Products Portfolio

Table 32: Waters Corporation Corporation Basic Information And Sales Area

Table 33: Waters Corporation Corporation. Products Portfolio

Table 34: Shimadzu Corporation Basic Information And Sales Area

Table 35: Shimadzu Corporation. Products Portfolio

Table 36: ThermoFisher Basic Information And Sales Area

Table 37: ThermoFisher. Products Portfolio

Table 38: Danaher Basic Information And Sales Area

Table 39: Danaher. Products Portfolio

Table 40: Hamilton Basic Information And Sales Area

Table 41: Hamilton. Products Portfolio

Table 42: Merck-Sigma Basic Information And Sales Area

Table 43: Merck-Sigma. Products Portfolio

Table 44: Bio-Rad Basic Information And Sales Area

Table 45: Bio-Rad. Products Portfolio

Table 46: Restek Basic Information And Sales Area

Table 47: Restek. Products Portfolio

Table 48: Dikma Technologies Basic Information And Sales Area

Table 49: Dikma Technologies. Products Portfolio

Table 50: Shepard Basic Information And Sales Area

Table 51: Shepard. Products Portfolio

Table 52: Idex Basic Information And Sales Area

Table 53: Idex. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Type

Table 55: Global Market Share (%) By Type (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global HPLC and UHPLC Columns Market Value (USD Million) By Region

Table 59: Global HPLC and UHPLC Columns Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Type

Table 62: North America Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Type

Table 65: Europe Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Type

Table 71: South America Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

FAQs

1. What is the current HPLC and UHPLC Columns market size?

Global HPLC and UHPLC Columns market size surpassed USD 1.9 billion in 2023, propelled by expanding pharmaceutical QA/QC workflows and food-safety testing mandates.

2. What growth rate is forecast for the next five years?

Analysts project a 5.8% CAGR through 2028, driven by biopharma patent cliffs, biosimilar pipelines, and rising adoption of sub-2 µm UHPLC formats.

3. Which factors are the primary market drivers?

Key drivers include stringent chromatographic purity standards, growing biologics output, demand for high-throughput analytics, and shift toward greener, low-solvent columns.

4. What challenges restrain faster expansion?

High column replacement costs, silica price volatility, complex regulatory validations, and competition from rapid LC-MS alternatives temper immediate growth velocity.

5. Which region leads consumption and innovation?

North America commands 38% share via robust CRO spending, FDA-driven compliance, and early uptake of superficially porous particle innovations in biopharma hubs.

6. Who are the top companies competing today?

Agilent, Waters, Thermo Fisher, Shimadzu, and Danaher (Phenomenex) dominate through wide portfolio breadth, global service networks, and locked-in pharma instrument-to-column ecosystems.

7. Where lie the biggest future opportunities?

Growth pockets include China biosimilar surge, monoclonal antibody analytics, green column chemistries, and hybrid silica-organic monoliths for continuous bioprocessing lines.

8. How is technology reshaping column design?

Sub-2 µm core-shell particles, 2D-LC multiplexing, elevated-temperature stable phases, and AI-optimized stationary chemistries deliver faster separations with minimal solvent consumption.

9. What impact do regulations have on adoption?

USP, EP, and ICH Q14 guidance mandate reproducible column qualification; compliance-ready certificates and eco-passports now gate entry into regulated pharma markets.

10. What is the future outlook for HPLC and UHPLC Columns?

The future outlook remains positive: personalized medicine, mRNA therapies, and real-time release testing will lift demand for highly selective, rapid-turnaround columns through 2030.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

HPLC and UHPLC Columns Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.80 million
Revenue forecast in 2033	2.70 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Agilent; Waters Corporation Corporation; Shimadzu Corporation; ThermoFisher; Danaher; Hamilton; Merck-Sigma; Bio-Rad; Restek; Dikma Technologies; Shepard; Idex
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options